We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AAM Blasts Bipartisan Bill Altering 180-Day Generic Exclusivity
AAM Blasts Bipartisan Bill Altering 180-Day Generic Exclusivity
The Association for Accessible Medicines is sounding the alarm on a House bill that would alter 180-day exclusivity for generics to allow for faster market entry of competitors.